Overexpression of GSE1 Related to Trastuzumab Resistance in Gastric Cancer Cells

Gastric cancer is one of the most prevalent human cancers with poor prognosis. Trastuzumab is a well-used targeted drug for gastric cancer with HER2 amplification. Trastuzumab resistance restrains the clinical use of trastuzumab. In this study, we reported human Gse1 coiled-coil protein (GSE1) promo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenbin, Wang, Shuanhu, Xu, A. man, Yuan, Xiao, Huang, Liguo, Li, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875631/
https://www.ncbi.nlm.nih.gov/pubmed/33623790
http://dx.doi.org/10.1155/2021/8834923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875631/
https://www.ncbi.nlm.nih.gov/pubmed/33623790
http://dx.doi.org/10.1155/2021/8834923

Ejemplares similares